ARCHIVES

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

This article is from The Cancer Letter archive.

Vol. 40 No. 05 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Friends Of Cancer Research Plan September Launch

August 9, 1996

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

ACS California Division Offers Fellowships For Clinical Research

June 14, 1996

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012